Psomagen, Inc. (KOSDAQ:950200)
South Korea · Delayed Price · Currency is KRW 3,440.00
-60.00 (-1.71%)
At close: Sep 3, 2026
Psomagen Market Cap
Psomagen has a market cap or net worth of 66.17 billion as of September 4, 2026. Its market cap has decreased by -12.13% in one year.
Market Cap
66.17B
Enterprise Value
65.12B
Revenue
60.70B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,440.00
ChartMarket Cap Chart
Since July 13, 2020, Psomagen's market cap has decreased from 254.61B to 66.17B, a decrease of -74.01%. That is a compound annual growth rate of -19.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 66.17B | -11.34% |
| Dec 30, 2025 | 74.64B | -4.20% |
| Dec 30, 2024 | 77.91B | -20.59% |
| Dec 28, 2023 | 98.10B | -34.17% |
| Dec 29, 2022 | 149.03B | -12.38% |
| Dec 30, 2021 | 170.10B | -50.35% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BIO-FD&C | 78.70B |
| SunBio,Inc. | 75.48B |
| CTCBIO | 74.36B |
| IMGT Co.,Ltd. | 71.33B |
| AriBioLab | 70.60B |
| ADBiotech | 68.45B |
| Naturalendo Tech | 67.88B |
| PanGen Biotech | 67.50B |